Product Brief
Cagrilintide is a long-acting amylin analog that complements GLP-1-based protocols by slowing gastric emptying and supporting satiety signaling. Often combined with Semaglutide or Tirzepatide in advanced metabolic programs.
As a long-acting amylin analog, Cagrilintide slows gastric emptying and enhances satiety signaling — making it a powerful adjunct to GLP-1 and dual-agonist protocols where appetite control is a primary goal.
Every Radiptide batch is manufactured under strict quality control and tested for identity and purity. Certificate of Analysis (COA) available on request.